BCL2 and cancer: It was shown that PZH’s anti-cancer activities might be related to the suppression of STAT3 signaling pathways, therefore resulting in the upregulation of Bax/Bcl-2 ratios as well as down-regulation of CCND1 and CDK4 expression.